文献速递血栓与止血

晚期胰腺癌患者的接触系统与内源性通路激活:一项前瞻性队列研究

Contact system and intrinsic pathway activation in patients with advanced pancreatic cancer: a prospective cohort study.
PubMed 文献 · J Thromb Haemost · 2023-06-16

这项前瞻性队列研究纳入109例晚期胰腺癌患者和22名对照者,基线采血并随访6个月,检测激肽释放酶、FXIIa和FXIa与天然抑制物形成的复合物。胰腺癌与PKa:C1-INH、FXIa:C1-INH和FXIa:AT复合物升高相关,高FXIa:α1at和高FXIa:AT与静脉血栓栓塞风险相关。

要点

  • 晚期胰腺癌患者中PKa:C1-INH、FXIa:C1-INH和FXIa:AT复合物较对照升高(P均<.001)。
  • 随访期间18例(16.7%)胰腺癌患者发生静脉血栓栓塞。
  • FXIa:α1at每对数升高亚分布风险比1.48(95%CI 1.02-2.16),FXIa:AT最高与较低四分位比亚分布风险比2.78(95%CI 1.10-7.00)。

核心结论

  • 蛋白酶与天然抑制物形成的复合物在癌症患者中升高,这些数据提示胰腺癌患者接触系统和内源性通路激活增加。

研究设计与样本

  • 前瞻性队列研究,纳入109例晚期胰腺癌患者与22名对照者,基线采血并随访6个月。
  • 检测激肽释放酶与C1酯酶抑制物复合物(PKa:C1-INH)、FXIIa与C1-INH复合物(FXIIa:C1-INH)、FXIa与C1-INH、抗凝血酶或α1抗胰蛋白酶复合物(FXIa:C1-INH、FXIa:AT、FXIa:α1at)。
  • 采用线性回归模型评估癌症与复合物水平的关联,校正年龄、性别和体重指数;采用竞争风险回归模型评估复合物水平与静脉血栓栓塞的关联。

主要发现

  • 癌症队列平均年龄66岁(SD 8.4),对照者平均年龄52岁(SD 10.1)。
  • 癌症队列中18例(16.7%)患者在随访期间发生静脉血栓栓塞。
  • 多变量回归模型中,胰腺癌与PKa:C1-INH(P<.001)、FXIa:C1-INH(P<.001)和FXIa:AT(P<.001)复合物升高相关。
  • 高FXIa:α1at与静脉血栓栓塞相关(亚分布风险比1.48每对数升高;95%CI 1.02-2.16)。
  • 高FXIa:AT与静脉血栓栓塞相关(亚分布风险比2.78最高与较低四分位比;95%CI 1.10-7.00)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Despite high risk of venous thromboembolism (VTE) in patients with pancreatic cancer, there are little data on contact system activation in these patients. OBJECTIVES: To quantify contact system and intrinsic pathway activation and subsequent VTE risk in patients with pancreatic cancer. METHODS: Patients with advanced pancreatic cancer were compared with controls. Blood was drawn at baseline and patients were followed for 6 months. Complexes of proteases with their natural inhibitors, C1-esterase inhibitor (C1-INH), antithrombin (AT), or alpha-1 antitrypsin (α1at), were measured for complexes containing kallikrein (PKa:C1-INH), factor (F)XIIa (FXIIa:C1-INH), and FXIa (FXIa:C1-INH, FXIa:AT, FXIa:α1at). The association of cancer with complex levels was assessed in a linear regression model, adjusted for age, sex, and body mass index. In a competing risk regression model, we assessed associations between complex levels and VTE. RESULTS: One hundred nine patients with pancreatic cancer and 22 controls were included. The mean age was 66 years (SD, 8.4) in the cancer cohort and 52 years (SD, 10.1) in controls. In the cancer cohort, 18 (16.7%) patients developed VTE during follow-up. In the multivariable regression model, pancreatic cancer was associated with increased complexes of PKa:C1-INH (P < .001), FXIa:C1-INH (P < .001), and FXIa:AT (P < .001). High FXIa:α1at (subdistribution hazard ratio, 1.48 per log increase; 95% CI, 1.02-2.16) and FXIa:AT (subdistribution hazard ratio, 2.78 highest vs lower quartiles; 95% CI, 1.10-7.00) were associated with VTE. CONCLUSION: Complexes of proteases with their natural inhibitors were elevated in patients with cancer. These data suggest that the contact system and intrinsic pathway activation are increased in patients with pancreatic cancer.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Bosch FTM, Campello E, Mulder FI, et al. Contact system and intrinsic pathway activation in patients with advanced pancreatic cancer: a prospective cohort study. J Thromb Haemost. 2023. PMID: 37331518. doi:10.1016/j.jtha.2023.06.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。